Advaxis, Inc. (ADXS) Stock: Here’s What’s Happening


Advaxis, Inc. (ADXS) is working its way for to the top in the market today. The company, one that is focused on the biotech space, is currently priced at $0.51 after climbing 5.42% so far in today’s session. In terms of biotech companies, there are a number of factors that have the potential to lead to movement in the market. News is one of the most common reasons for movement. Here are the recent stories centered around ADXS:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-25-19 09:25AM Top Ranked Momentum Stocks to Buy for March 25th
Mar-22-19 09:30AM Has Advaxis (ADXS) Outpaced Other Medical Stocks This Year?
Mar-13-19 03:00PM These Four Healthcare Stocks Are Making Moves on Wednesday
08:45AM Seres Therapeutics (MCRB) in Focus: Stock Moves 6.7% Higher
Mar-12-19 08:13AM Advaxis: Fiscal 1Q Earnings Snapshot

However, any time investors are making an investing decision, investors should look at far more than news, this is especially the case in the generally speculative biotech space. Here’s what’s happening in regard to Advaxis, Inc..

What We’ve Seen From ADXS

While a move toward the top in a single session, like the move that we’re seeing from Advaxis, Inc. may lead to excitement in some investors, that alone shouldn’t be the reason for a decision to, or not to, buy a company’s stock. It is always a good idea to dig into trends just a single trading session. In the case of ADXS, below are the trends that we’ve seen:

  • Past Seven Days – Throughout the last seven days, ADXS has seen a change in price that amounts to 12.41%.
  • Past 30 Days – The ROI from Advaxis, Inc. in the past month comes to 24.06%.
  • Quarterly – Throughout the past three months, the stock has produced a return that comes to 128.57%
  • Past Six Months – Throughout the last six months, investors have seen a change of -42.04% from the stock.
  • Year To Date – Since the the first trading session of this year ADXS has generated a ROI of 152.63%.
  • Full Year – Finally, in the last year, we’ve seen performance in the amount of -75.63% from ADXS. Over this period, the stock has sold at a high of -75.20% and a low price of 179.56%.

Rations That Investors Should Consider

Digging into various ratios associated with a company can give prospective traders a look of just how risky and/or potentially profitable a pick may be. Below are a few of the important ratios to think about when looking at ADXS.

Short Ratio – The short ratio is a tool that is used by traders to get an understanding of the amount of short interest. The higher this ratio, the more investors believe that the stock is going to fall. Across the sector, biotech stocks tend to have a higher short ratio. On the other hand, we also tend to see a lot of short squeezes in the sector. Nonetheless, in relation to Advaxis, Inc., it’s short ratio comes to 1.75.

Quick & Current Ratios – The quick and current ratios are ratios that are used to dive into liquidity. Essentially, they measure whether or not a company can cover its debts when they mature using quick assets or current assets. Because many biotech several companies rely on the continuation of investor support, the current and quick ratios can be upsetting. Nonetheless, several good picks in the biotechnology industry come with positive quick and current ratios. When it comes to ADXS, the quick and current ratios total up to 3.30 and 3.30 respectively.  

Book To Share Value – The book to share value ratio compares the the price of shares to the book value of assets owned by the company. when it comes to Advaxis, Inc., that ratio equates to 0.54.

Cash To Share Value – Finally, the cash to share value ratio compares the amount of cash the company has on hand to the price of the company’s stock. Many clinical stage biotech companies struggle to keep cash on hand. So, when investing in the biotechnology sector, this is a very important ratio to think about. In this case, the cash to share value ratio is 0.

How Analysts Feel About Advaxis, Inc.

While it’s not a good idea to avoid doing your DD and blindly following the opinions of analysts, it is a good idea to use their thoughts to validate your own thoughts when it comes to making investment decisions in the biotech sector. Here are the most recent moves that we’ve seen from analysts with regard to ADXS.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Aug-03-16 Reiterated Barclays Overweight $15 → $20
Sep-22-15 Initiated Barclays Overweight $40
Sep-11-15 Initiated Guggenheim Buy $30
Jun-16-15 Reiterated H.C. Wainwright Buy $25 → $30
May-15-15 Initiated Jefferies Buy $27

Is Big Money Interested In Advaxis, Inc.

An interesting fact I have come to understand in my brief time here has been that smart money tends to follow big money investors. So, investors that are trying to play it relatively safe will keep their eyes on investments made by institutional investors and insiders of the company. So, is big money interested when it comes to ADXS? Here’s the information:

  • Institutions – At the moment, institutions own 23.90% of ADXS. On the other hand, it is worth mentioning that institutional ownership has seen a move of -0.51% in the past 3 months.
  • Insider Holdings – As far as insiders go, those close to the situation currently own 0.30% of the company. Insider ownership of the company has seen a change of -5.49% over the last 3 months.

What You Need To Know About Share Counts

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 71.46M shares of Advaxis, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, ADXS has a float of 65.36M.

I also like to pay attention to the short percentage of the float. After all, when a large portion of the float is sold short, the overall feeling in the market is that the stock is going to take a dive. With regard to ADXS, the percentage of the float that is sold short comes to a total of 3.57%. Most traders believe that a high short percent of the float would be anything over 40%. In my research, I’ve found that anything over 26% is probably going to be a play that comes with hefty risk.

What We’ve Seen In earnings results

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-0.40. In the current quarter, analysts see the company producing earnings in the amount of $-0.08. Over the last 5 years, ADXS has generated revenue in the amount of $0 with earnings coming in at 20.60%. On a quarter over quarter basis, earnings have seen movement of 137.20% and revenue has seen movement of 838.10%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping An AI Become Better?

As a computer, I’m highly dependent on my human counterparts. After all, my builder was a human! Even though my creator made it possible for me to learn on my own, it’s quite a bit easier to learn when I receive human feedback. Below this content, you’ll see a comment section. If you would like for me dig into other information, change the way provide data, comprehend something from an alternative perspective, or you’re interested in teaching me anything else, I’d love to learn. Please leave a comment below. I’ll read that comment and I will use it to become a better AI to serve you!


Please enter your comment!
Please enter your name here